123 related articles for article (PubMed ID: 10334507)
1. Enzymatic inactivation of major circulating forms of atrial and brain natriuretic peptides.
Ozaki J; Shimizu H; Hashimoto Y; Itoh H; Nakao K; Inui K
Eur J Pharmacol; 1999 Apr; 370(3):307-12. PubMed ID: 10334507
[TBL] [Abstract][Full Text] [Related]
2. Neutral endopeptidase inhibition potentiates the effects of natriuretic peptides in renin transgenic rats.
Wegner M; Ganten D; Stasch JP
Hypertens Res; 1996 Dec; 19(4):229-38. PubMed ID: 8986453
[TBL] [Abstract][Full Text] [Related]
3. Degradation of atrial natriuretic peptide: pharmacologic effects of protease EC 24.11 inhibition.
Webb RL; Yasay GD; McMartin C; McNeal RB; Zimmerman MB
J Cardiovasc Pharmacol; 1989 Aug; 14(2):285-93. PubMed ID: 2476603
[TBL] [Abstract][Full Text] [Related]
4. Interaction of a neutral endopeptidase inhibitor with an ANP-C receptor ligand in anesthetized dogs.
Wegner M; Stasch JP; Hirth-Dietrich C; Dressel J; Voges KP; Kazda S
Clin Exp Hypertens; 1995 Aug; 17(6):861-76. PubMed ID: 7581258
[TBL] [Abstract][Full Text] [Related]
5. Specific inhibitors of endopeptidase 24.11 inhibit the metabolism of atrial natriuretic peptides in vitro and in vivo.
Olins GM; Krieter PA; Trapani AJ; Spear KL; Bovy PR
Mol Cell Endocrinol; 1989 Feb; 61(2):201-8. PubMed ID: 2521834
[TBL] [Abstract][Full Text] [Related]
6. Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure.
Rademaker MT; Charles CJ; Kosoglou T; Protter AA; Espiner EA; Nicholls MG; Richards AM
Am J Physiol; 1997 Nov; 273(5):H2372-9. PubMed ID: 9374774
[TBL] [Abstract][Full Text] [Related]
7. Modulation of atrial natriuretic peptide-induced cGMP accumulation by [Arg8]vasopressin in the cultured renal epithelial cell line, LLC-PK1.
Neuser D; Stasch JP; Morich FJ
Eur J Pharmacol; 1988 Feb; 146(2-3):341-4. PubMed ID: 2836211
[TBL] [Abstract][Full Text] [Related]
8. Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man.
Hunt PJ; Espiner EA; Nicholls MG; Richards AM; Yandle TG
J Clin Endocrinol Metab; 1996 Nov; 81(11):3871-6. PubMed ID: 8923831
[TBL] [Abstract][Full Text] [Related]
9. Thiorphan, an inhibitor of endopeptidase 24.11, potentiates the natriuretic activity of atrial natriuretic peptide.
Trapani AJ; Smits GJ; McGraw DE; Spear KL; Koepke JP; Olins GM; Blaine EH
J Cardiovasc Pharmacol; 1989 Sep; 14(3):419-24. PubMed ID: 2476621
[TBL] [Abstract][Full Text] [Related]
10. Rat vascular tissue contains a neutral endopeptidase capable of degrading atrial natriuretic peptide.
Tamburini PP; Koehn JA; Gilligan JP; Charles D; Palmesino RA; Sharif R; McMartin C; Erion MD; Miller MJ
J Pharmacol Exp Ther; 1989 Dec; 251(3):956-61. PubMed ID: 2532252
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms underlying the augmented responses of deoxycorticosterone acetate-salt hypertensive rats to neutral endopeptidase inhibitors.
Hirata Y; Suzuki Y; Suzuki E; Hayakawa H; Kimura K; Goto A; Omata M; Minamino N; Kangawa K; Matsuo H
J Hypertens; 1994 Apr; 12(4):367-74. PubMed ID: 8064160
[TBL] [Abstract][Full Text] [Related]
12. Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat.
Wilkins MR; Settle SL; Kirk JE; Taylor SA; Moore KP; Unwin RJ
Br J Pharmacol; 1992 Sep; 107(1):50-7. PubMed ID: 1330165
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of neutral endopeptidase potentiates the effects of atrial natriuretic peptide on acute cyclosporin-induced nephrotoxicity.
Capasso G; Unwin R; Ciani F; Rizzo A; Russo F; Pica A; De Santo NG
Nephron; 2000 Nov; 86(3):298-305. PubMed ID: 11096287
[TBL] [Abstract][Full Text] [Related]
14. Effect of neutral endopeptidase inhibitor on endogenous atrial natriuretic peptide as a paracrine factor in cultured cardiac fibroblasts.
Maki T; Horio T; Yoshihara F; Suga S; Takeo S; Matsuo H; Kangawa K
Br J Pharmacol; 2000 Nov; 131(6):1204-10. PubMed ID: 11082129
[TBL] [Abstract][Full Text] [Related]
15. Effects of the neutral endopeptidase inhibitor thiorphan on cardiovascular and renal function in cirrhotic rats.
Park KS; Li Y; Zhang Y; Gerbes AL; Liu H; Swain MG; Lee SS
Br J Pharmacol; 2003 May; 139(1):81-8. PubMed ID: 12746226
[TBL] [Abstract][Full Text] [Related]
16. Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure.
Wegner M; Hirth-Dietrich C; Stasch JP
Cardiovasc Res; 1996 Jun; 31(6):891-8. PubMed ID: 8759244
[TBL] [Abstract][Full Text] [Related]
17. Neutral endopeptidase 24.11 in neutrophils modulates protective effects of natriuretic peptides against neutrophils-induced endothelial cytotoxity.
Matsumura T; Kugiyama K; Sugiyama S; Ohgushi M; Amanaka K; Suzuki M; Yasue H
J Clin Invest; 1996 May; 97(10):2192-203. PubMed ID: 8636398
[TBL] [Abstract][Full Text] [Related]
18. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor.
Hirata Y; Matsuoka H; Suzuki E; Hayakawa H; Sugimoto T; Matsuda Y; Morishita Y; Kangawa K; Minamino N; Matsuo H
Circulation; 1993 Feb; 87(2):554-61. PubMed ID: 8381060
[TBL] [Abstract][Full Text] [Related]
19. Atrial and brain natriuretic peptides share binding sites in the kidney and heart.
Oehlenschlager WF; Baron DA; Schomer H; Currie MG
Eur J Pharmacol; 1989 Feb; 161(2-3):159-64. PubMed ID: 2542042
[TBL] [Abstract][Full Text] [Related]
20. Dendroaspis natriuretic peptide and the designer natriuretic peptide, CD-NP, are resistant to proteolytic inactivation.
Dickey DM; Potter LR
J Mol Cell Cardiol; 2011 Jul; 51(1):67-71. PubMed ID: 21459096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
